FDA, Medical Device Industry and NORD Announce New Public-Private Partnership

First-ever PPP Created to Focus Exclusively on Advancing Medical Device Regulatory Science

The founding members of the new partnership, which will be called the Medical Device Innovation Consortium (MDIC), are LifeScience Alley, a biomedical science trade association; several companies involved in developing medical devices; and NORD (the National Organization for Rare Disorders), in partnership with the U.S. Food and Drug Administration (FDA).

The mission of MDIC will be to foster innovation, increase the tools available to evaluate new medical devices to assure that they are safe and effective, and ensure that innovative devices get to patients as quickly as possible while still protecting public health.

MDIC will draw together experts from FDA, the medical device industry, academia and related organizations to improve health through the application of shared knowledge.  Specific goals include:

  • To ensure that innovative technology is readily available to U.S. patients
  • To make the medical device regulatory process more expeditious, transparent and effective
  • To reduce the risk and expense of clinical research and
  • To reduce the time and cost of medical device development.

Source: Rarediseases website, Dec 3rd 2012

Read more at:

http://www.rarediseases.org/news-events/news/ppp-medical-device